Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Glucose intolerance during hormonal therapy for prostate cancer

Prostate Cancer and Prostatic Diseases volume 10, pages 384–387 (2007)Cite this article

Abstract

The aim of this study was to examine the influence of hormonal therapy (HT) on glucose metabolism in prostate cancer (PCa) patients. Fifty-two PCa patients receiving HT with gonadotropin-releasing hormone (GnRH) analogues and/or antiandrogen drugs were enrolled in this study. Both blood and urine samples were taken a few hours after breakfast before and after HT, and glucose levels in the blood and urine were measured. Elevations of blood glucose levels of 30–50, 50–100 and over 100 mg/dl after HT as compared with the levels before HT were observed in two, eight and five patients, respectively. Urine examination revealed deterioration of glucosuria in seven patients. The mean blood glucose level after HT was significantly higher than that measured before HT. The elevation of blood glucose level significantly correlated with concurrence of diabetes mellitus (DM) and higher body mass index (BMI) before HT. Deterioration of glucosuria significantly correlated with the concurrence of DM. HT for PCa patients, especially with concurrent DM or obesity, induces elevation of the blood glucose level and deterioration of glucosuria. Therefore, glucose intolerance should be considered during HT for PCa.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Okihara K, Nakanishi H, Nakamura T, Mizutani Y, Kawauchi A, Miki T . Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing. Int J Urol 2005; 12: 662–667.

    Article  Google Scholar 

  2. Cancer registration committee of the Japanese Urological Association. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol 2005; 12: 46–61.

    Article  Google Scholar 

  3. Suzuki K, Kobayashi M, Tokue A . Clinical evaluation of hot flushes developing during endocrine therapy for prostate carcinoma. Nippon Hinyokika Gakkai Zasshi 2003; 94: 614–620.

    PubMed  Google Scholar 

  4. Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD et al. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in male with prostate cancer. J Clin Endocrinol Metab 2001; 86: 4261–4267.

    Article  CAS  Google Scholar 

  5. Basaria S, Lieb II J, Tang AM, DcWeese T, Carducci M, Eisenberger M et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 2002; 56: 779–786.

    Article  CAS  Google Scholar 

  6. Smith MR . Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 2004; 63: 742–745.

    Article  Google Scholar 

  7. Smith MR, Finkelstein JS, McGovern FJ, Zictman AL, Fallon MA, Schoenfeld DA et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 2002; 87: 599–603.

    Article  CAS  Google Scholar 

  8. Inaba M, Otani Y, Nishimura K, Takaha N, Okuyama A, Koga M et al. Marked hyperglycemia after androgen-deprivation therapy for prostate cancer and usefulness of pioglitazone for its treatment. Metabolism 2005; 54: 55–59.

    Article  CAS  Google Scholar 

  9. Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS . Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 2006; 106: 581–588.

    Article  CAS  Google Scholar 

  10. Schattner A, Katz-Porat BS, Gindin Y, Geltner D . Cyproterone-induced hyperosmolar hyperglycemia. Drug Intell Clin Pharm 1988; 22: 632–633.

    Article  CAS  Google Scholar 

  11. Coddington CC, Hassiakos DK, Harrison HC, Brzyski RG, Jones GS . Effect of a gonadotropin-releasing hormone analogue on the glucose metabolism in a diabetic patient. Gynecol Obstet Invest 1990; 30: 246–248.

    Article  CAS  Google Scholar 

  12. Morimoto S, Fernandez-Mejia C, Romero-Navarro G, Morales-Peza N, Diaz-Sanchez V . Testosterone effect on insulin content, messenger ribonucleic acid levels, promoter activity, and secretion n the rat. Endocrinology 2001; 142: 1442–1447.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Jichi Medical University, Tochigi, Japan

    K Suzuki, A Nukui & T Morita

  2. Department of Urology, Utsunomiya Shakaihoken Hospital, Tochigi, Japan

    K Suzuki & Y Hara

Authors
  1. K Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Nukui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Suzuki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, K., Nukui, A., Hara, Y. et al. Glucose intolerance during hormonal therapy for prostate cancer. Prostate Cancer Prostatic Dis 10, 384–387 (2007). https://doi.org/10.1038/sj.pcan.4500976

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500976

Keywords

This article is cited by

Search

Advanced search

Quick links